Oncology

• Economic evaluation of zoledronic acid for the prevention of osteoporotic
  fractures in postmenopausal women with early-stage breast cancer receiving
  aromatase inhibitors in the UK.

  Date: 12-2-2009  |  Category: Oncology
  Logman JF, Heeg BM, Botteman MF, Kaura S, van Hout BA. Annals of Oncology 2009 [Epub ahead of print] 

  ---

• A review of the clinical and economic outcomes of imatinib in Philadelphia chromosome positive acute lymphoblastic leukemia.

  Date: 1-1-2007  |  Category: Oncology
  Carpiuc KT, Stephens J, Botteman M, Feng W, Hay J. Expert Opinion of Pharmacotherapy 2007;8(16):2775-87. Review

  ---

• Economic burden of haematological adverse effects in cancer patients. A systematic review.

  Date: 1-1-2007  |  Category: Oncology
  Liou SY, Stephens JM, Carpiuc KT, Feng W, Botteman MF, Hay JW. Clin Drug Invest 2007;27(6):381-396.

  ---

• The economic burden of endometriosis.

  Date: 1-1-2006  |  Category: Oncology
  Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL. Fertility and Sterility 2006;86(6):1561-72.

  ---

• Health-related quality of life burden of women with endometriosis: a literature review.

  Date: 1-1-2006  |  Category: Oncology
  Gao X, Yeh Y, Outley J, Simon J, Botteman M, Spalding J. Curr Med Res Opin 2006;22(9):1787-97.

  ---

• Cost effectiveness of bisphosphonates in the management of breast cancer patients with bone metastases.

  Date: 1-1-2006  |  Category: Oncology
  Botteman M, Barghout V, Stephens J, Hay J, Brandman J, Aapro M. Ann Oncol 2006;17(7):1072-82.

  ---

• Preferences and utilities of health outcomes and treatments associated with head and neck cancer: a systematic review.

  Date: 1-1-2006  |  Category: Oncology
  Komatsuzaki Y, Gramegna P, Stephens JM, Botteman MF, Pashos CL, Redaelli A. American Journal of Cancer 2006;5(1): 27-34.

  ---

• Chronic lymphocytic leukemia: economic burden and quality of life: literature review.

  Date: 1-1-2005  |  Category: Oncology
  Stephens JM, Gramegna P, Laskin B, Botteman MF, Pashos CL. Am J Ther. 2005;12(5):460-6.

  ---

• Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.

  Date: 1-1-2005  |  Category: Oncology
  Smith MR, Lee WC, Brandman J, Wang Q, Botteman M, Pashos CL. J Clin Oncol. 2005;23(31):7897-903. 

  ---

• A systematic literature review of the clinical and epidemiological burden of acute lymphoblastic leukaemia (ALL).

  Date: 1-1-2005  |  Category: Oncology
  Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. Eur J Cancer Care (Engl). 2005;14(1):53-62.

  ---

• Het leven verbeterd of bedreigd? Epoetine omstreden als ondersteuning bij de behandeling van kanker.

  Date: 1-1-2004  |  Category: Oncology
  Jacobs BS, Klijn JS, Logman JFS, Schellens JHM. Pharm Weekbl 2004;139(51):1741-16. In Dutch. 

  ---

• Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy.

  Date: 1-1-2004  |  Category: Oncology
  Groenewoud JH, Pijnappel RM, van den Akker-Van Marle ME, Birnie E, Buijs-van der Woude T, Mali WP, de Koning HJ, Buskens E. Br J Cancer. 2004;90(2):383-92.

  ---

• Economic burden of head and neck cancer. A literature review.

  Date: 1-1-2004  |  Category: Oncology
  Lee JM, Turini M, Botteman MF, Stephens JM, Pashos CL. Eur J Health Econ. 2004;5(1):70-80. 

  ---

• The clinical and epidemiological burden of chronic lymphocytic leukaemia.

  Date: 1-1-2004  |  Category: Oncology
  Redaelli A, Laskin BL, Stephens JM, Botteman MF, Pashos CL. Eur J Cancer Care (Engl). 2004;13(3):279-87. 

  ---